technical infrastructure

The FDA has begun using generative AI to review drug submissions, signaling a major shift in regulatory review. Learn how this impacts pharma teams and what it takes to make your content AI-ready.

The AI landscape is evolving rapidly. While pre-configured workflows have powered automation for years, the next frontier lies in intelligent AI agents—systems that can plan, adapt and execute tasks dynamically rather than following static scripts.